Can Breast Magnetic Resonance Imaging Demonstrate Characteristic Findings of Preoperative Ductal Carcinoma In Situ in Taiwanese Women?  by Leung, Ting-Kai et al.
ASIAN JOURNAL OF SURGERY VOL 33 • NO 3 • JULY 2010 143
© 2010 Elsevier. All rights reserved.
Original Article
Can Breast Magnetic Resonance Imaging
Demonstrate Characteristic Findings of Preoperative
Ductal Carcinoma In Situ in Taiwanese Women?
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OBJECTIVE: Magnetic resonance imaging (MRI) is more sensitive than mammography and sonography
for breast cancer detection, but its diagnostic specificity is still being debated, and standardised criteria
are lacking.
METHODS: This study used a dedicated breast MRI system with a Spiral RODEO pulse sequence, and
applied postprocessing techniques including multiplanar reformation (MPR) with ductal orientation,
early subtracted phase (ESP) and a postcontrast kinetic curve. We discuss the possible MRI/pathology
correlations based on pathogenetic concepts. We retrospectively collected data from 13 cases of benign intra-
ductal and early-stage malignant lesions to observe the capability of MPR, ESP and kinetic curve techniques
to diagnose early lesions differentially. MRI features and pathological findings for these cases were collected.
RESULTS: Thirteen cases of ductal carcinoma in situ with MRI characteristics and pathological findings
were identified. We analysed early ductal lesions, such as intraductal epithelial hyperplasia, intraductal
papilloma, ductal carcinoma in situ and small focal invasive ductal carcinoma. Using MRI with MPR to
demonstrate ductal orientation, we found 12 cases with a ductogram appearance and 6 with crossing-over
glandular tissue. The tumour size estimated by MRI was accurate in 6 cases, but overestimated in seven.
CONCLUSION: Dedicated breast MRI with MPR, ESP and kinetic curve analyses might be helpful in
defining some characteristics of early-stage malignant lesions. [Asian J Surg 2010;33(3):143–9]
Key Words: breast cancer in Taiwan, breast MRI, ductal carcinoma in situ
Introduction
Breast magnetic resonance imaging (MRI) has the high-
est negative predictive value and most accurate sensitivity
of all breast screening modalities.1 It is a useful assessment
tool for determining stages of invasive cancer. However,
there is some doubt about its use for distinguishing ductal
carcinoma in situ (DCIS) from benign and atypical prolif-
erative processes.2
The incidence of DCIS of the breast seems to be grad-
ually increasing. DCIS shows different grades of malig-
nant potential, and certain subtypes of DCIS are more
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likely to recur. Approximately 60% of women with DCIS
will progress to invasive ductal carcinoma (IDC) over an
8–10-year period, and poor prognostic outcomes are likely
when IDC develops.1,3 Thus, the early detection of DCIS
through imaging studies that permit accurate assessment
of size and distribution is important.
Early-stage DCIS should appear in a spread-out pat-
tern that extends toward the nipple, and is occasionally seen
in breast tissue peripheral to infiltrating carcinoma. Only
three-dimensional (3D) demonstrations of imaging and
pathology can actually be correlated with each other.
Sonography and mammography are not capable of showing
the anatomical and spatial relationship between the lesion
and the ductal structures within the breast (Figure 1).
Here, we report a few cases of DCIS, and determine the
potential of breast MRI with multiplanar reformation
(MPR) and ductal orientation for identification of DCIS,
and specifically, its extent of distribution.
Image acquisition protocols range from dynamic
studies to high spatial resolution imaging, but there is a
lack of standardized criteria for interpreting them. We
used Spiral RODEO pulse sequence and different post-
processing techniques, including MPR with ductal orien-
tation, early subtracted phase (ESP) and postcontrast kinetic
curve, which can be independently applied in a dedicated
breast MRI (DBMRI) system. We retrospectively collected
data from cases of benign intraductal and early-stage
malignant lesions to observe the ability of DBMRI to dif-
ferentiate these entities. We also discuss MRI/pathology
correlations based on pathogenic concepts, in an effort to
improve understanding of the histological heterogeneity
of early breast cancer and to generate diagnostic criteria.1
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Figure 1. Relationship of mammary duct with glandular tissue
and nipple.
Materials and methods
From March 2008 to February 2010, 1,005 Taiwanese
women were checked for breast cancer using DBMRI with
MPR for ductal orientation, based on the Spiral RODEO
pulse sequence. These included 13 women (age range:
36–69 years; mean age: 47.5 ± 8.4 years) diagnosed with
DCIS who underwent DBMRI with MPR. Patients with pre-
operative tissue-proven diagnosis who received DBMRI
were excluded from this study. Patients who underwent
excision or mastectomy were also excluded. Cases selected
for this retrospective study were found to have early intra-
ductal lesions.
Pre-enhanced and postenhanced subtracted images
were obtained, and an enhanced curve analysis was per-
formed. All imaging studies were performed on a 1.5 T
dedicated spiral breast MRI system (Aurora Systems, 
San Jose, CA, USA). For the screening procedure, patients
were placed in a prone position, feet first, on the table
inside the DBMRI machine. Breasts were fitted and posi-
tioned using a breast transmission–receiving (TR) coil.
The off-resonance spiral image mode was used. A gradient
echo with 10 milliseconds of TR and T2-weighted spin echo
with 2.5 milliseconds of TR were acquired. The echo time
was 5 milliseconds for RODEO and 120 milliseconds for
the T2 sequences. The matrix size was 512 × 512. The slice
thickness was 1.1 mm. The field of view of each station was
20–36 cm. Sequences were performed before and after the
infusion of 0.2 mmol/kg gadolinium-diethylenetriamine
penta-acetic acid (Magnevist; Bayer-Schering Pharma AG,
Berlin, Germany), administered as a bolus dose with a
power injector, followed by a 20-mL saline flush. Subtraction
images were also performed. To evaluate the haemody-
namic characteristics of the lesion, an enhanced curve as
well as a colour mapping programme were obtained. An
early subtracted phase of the images was obtained by sub-
traction of the postenhanced phase of images at 90 seconds
and nonenhanced images. Using the mean percentage cal-
culation and comparing precontrast and postcontrast
kinetic data acquisition (calculated for 0, 90, and 270 sec-
onds), the threshold point for lesion enhancement was dis-
placed. According to diagnostic observations of Christane
Kuhl et al,4 curved patterns of the plateau and washout
with bound protein water and free water represent possi-
ble lesions. The oblique display protocol of AuroraCad 4.0
(Aurora System, North Andover, MA, USA) displayed data
acquired from the 3D maximum intensity projection
(MIP) image of the first postcontrast injection, and then
output the selected plane of orientation as an oblique
MPR on side-by-side display windows. We controlled the
rotation of the 3D MIP from any angle, and the MPR
pane was updated to match the slice, while having the
same orientation as the MIP (Figure 2A and 2B).
Screening for cases with ductogram appearance was
performed to establish whether there was a significant
correlation between DCIS and ductograms. We used the
term ductogram to predict image phenomena that
occurred when there was periductal infiltration in the tis-
sues immediately adjacent to the mammary duct, espe-
cially when tumour cell infiltration was enhanced after
the postcontrast phase. “Crossing-over glandular pat-
tern” represented a solid mass that extended over the
mammary duct, with a solid-mass-like appearance. “Strip”
pattern referred to an image that looked like infiltration
that spread along the ductal mesh work. Ductogram
image findings were observed when the non-contrast ductal
structures appeared distinct from the enhanced periduc-
tal tumour infiltration, if the ductal orientation was
observed in phases using MPR.
Results
Initially, 13 cases were suspected of being malignancies,
and were finally proven by pathology to be pure DCIS,
benign intraductal lesions, or small IDC. Nine cases (69.2%)
were the pure-type DCIS without an invasive component
(Table 1). The interpretation of DBMRI and pathological
findings are summarized in Table 2. All cases displayed
washout and plateau parts within the lesion on the
postenhanced curve patterns. Twelve cases (92.3%) had a
ductogram appearance, and there was only one case (7.7%;
case 6) without a ductogram (Table 3). Six cases (46.2%) in-
volved crossing-over glandular tissue, and these six also had
a ductogram appearance that was mostly of mixed type.
Table 4 shows the tumour size estimated by MRI com-
pared to pathological evidence. The size of DCIS was over-
estimated in seven of the 13 cases that were confirmed by
pathology. MRI estimated the tumour size accurately in
six cases (46.1%), but MRI overestimated tumour size by
1–2-fold in four cases (30.8%), and by > 2-fold in three
cases (23.1%). Of the six cases for which MRI accurately
estimated tumour size, all but one was pure-type DCIS
(Case 13). Nine cases were positive for oestrogen receptor
(ER) and four cases were negative.
Two cases of pure DCIS (Cases 1 and 6) and two of
DCIS with IDC (Cases 10 and 11) were overestimated by
1.5, 3, 2 and 2 times, respectively, and all were negative for
ER. Seven cases showed approximately the same size or
less than 1.2 times the pathological size, and were positive
for ER. The remaining pure-type DCIS, when revealed by
MPR for ductal orientation, only appeared as a nonmass
with intensity, and except for Case 9, MRI overestimated
tumour size by one or two times compared with the
pathological size.
The sixth case was the most seriously overestimated by
MRI; the pure DCIS part of this case was associated with
two individual fibroadenomas and apocrine metaplasia,
with a focal, foreign body giant-cell reaction. Four of the
nine pure-type DCIS cases exhibited a nonmass morphol-
ogy with thin or thick strip-like intensities, which spread
along the glandular tissue, as revealed by MPR with duc-
tal orientation. Figure 3 shows the MPR of breast MRI of
Cases 1–13.
Apart from these results, we also show three cases of
non-DCIS early ductal lesions, including intraductal
papilloma, ductal hyperplasia and early focal IDC, which
could be demonstrated effectively by MPR with ductal
orientation. Although some characteristics of the lesion
morphology were similar to the Figure 3 pictures, in terms
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Figure 2. By controlling the rotation of the 3D maximum inten-
sity projection (A) from any angle rotation, multiplanar reforma-
tion updates to match the slice in the same orientation as the
new orientation of the maximum intensity projection (B).
Table 1. Prevalence of ductal carcinoma in situ (DCIS) and DCIS
with intraductal carcinoma (IDC) in this study
Pure DCIS DCIS + IDC
No. of cases 9 4
Prevalence (%) 69.2 30.8
subtracted in the early phase, but not the third case
(Figure 4C), which could help to differentiate benign
lesions from malignant ones.
In our experience with a DBMRI system with Spiral
RODEO pulse sequence, the possibility of malignancy
could be almost completely excluded from lesions that could
be subtracted in the ESP. Among our cases, there were only
two exceptions that showed malignant cases being sub-
tracted in the EPS (at 90 seconds), but not in the late phase
(270 seconds). The reason for these false negatives (early sub-
traction images) was technical error that involved the con-
trast injection and incorrect timing of image acquisition.
Discussion
Improvements in magnetic resonance technology, such as
higher spatial resolution, 3D anatomical demonstration
and functional analysis based on dynamic postenhancement
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Table 2. Interpretation of dedicated breast magnetic resonance imaging and pathological findings
Case no.
Corresponding areas MRI size compare with 
Pathological Oestrogen
of postenhanced pathological size 
curve pattern (by largest dimension)
diagnosis receptor
1 (Figure 3A) Plateau/washout 1.5:1 (0.6 cm:0.4 cm) Pure-type DCIS Negative
2 (Figure 3B) Washout 1.2:1 (1.2 cm:1.0 cm) Pure-type DCIS Positive
3 (Figure 3C) Washout 1:1 (3 cm:3 cm) Pure-type DCIS (Intraductal papilloma Positive
with apocrine metaplasia and
florid ductal epithelial hyperplasia)
4 (Figure 3D) Washout 1:1 (1.2 cm:1.2 cm) Pure-type DCIS (high grade) Positive
5 (Figure 3E) Plateau/washout 1.5:1 (2.4 cm:1.6 cm) Pure-type DCIS arising from Positive
intraductal papilloma
6 (Figure 3L) Plateau/washout 3:1 (1.5 cm:0.5 cm) Pure-type DCIS; Negative
two fibroadenomas and associated 
apocrine metaplasia and focal 
foreign body giant-cell reaction
7 Rt (Figure 3F) Washout 2:1 (6.5 cm:3.1 cm) Pure DCIS, extensive Positive
8 (Figure 3I) Plateau 2:1 (6 cm:3.2 cm) Pure DCIS arising from intraductal Positive
papilloma; tiny focus of atypical 
ductal hyperplasia
9 (Figure 3M) Washout 1:1 (2.3 cm:2.2 cm) DCIS with radial scar and proliferative Positive
component
10 (Figure 3G) Washout 1.5:1 (4.1 cm:3.1 cm) IDC and fibroadenoma with extensive Negative
DCIS with focal micro-invasion
11 (Figure 3H) Washout 1:1 (2.4 cm:2.2 cm) DCIS, high grade, with IDC in two Negative
small foci
12 Lt (Figure 3J) Washout 1:1 (2.1 c:2.0 cm) IDC with extensive DCIS Positive
13 (Figure 3K) Washout 1:1 (1.7 cm:1.6 cm) IDC with DCIS Positive
DCIS = ductal carcinoma in situ; IDC = intraductal carcinoma; Rt = right; Lt = left.
Table 3. Cases with or without ductogram appearance
Ductogram No ductogram
No. of cases 12 1
Percentage (%) 92.3 7.7
Table 4. Tumour size estimated by magnetic resonance imaging
(MRI) compared with pathology
MRI size:pathological size 1:1 1–2:1 > 2:1
No. of cases 6 4 3
Percentage (%) 46.1 30.8 23.1
of tumour size and spreading along glandular tissue, not
all exhibited a ductogram appearance. However, addi-
tional analysis by early subtracted images and postcontrast
kinetic curves could help to confirm the image diagnosis,
because the first two cases (Figures 4A and 4B) could be
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Figure 3. Nonmass. (A) Characteristic ductogram (long arrow) and thin strip appearance that spread
along glandular tissue was demonstrated in Case 1. (B) Characteristic ductogram (long arrow) and
thick and thin strip appearance that spread along glandular tissue was demonstrated in case 2. 
(C) Case 3 showed characteristic ductogram pattern (long arrow) and thin strip appearance along the
lactiferous sinus and duct to the areola, with crossing-over glandular tissue, within the background of
striping and nonmass signal intensity. (D) Case 4 pure-type DCIS showed an intermediate grade of
malignancy with delayed surgical treatment, in which the ductogram (long arrow) and thin strip appear-
ance were preserved. The MPR for ductal orientation manifested as nonmass with striped appearance,
and the lesion crossover glandular tissue. (E) Case 5 of pure DCIS, which manifested with nonmass like
intensity (curved arrow) and ductogram (long arrow) with thin striped appearance. (F) Characteristic
ductogram appearance (long arrow) and thin strip appearance that spread along glandular tissue
was demonstrated in Case 7. (G) Characteristic ductogram (long arrow) and thick strip appearance that
spread along glandular tissue was demonstrated in Case 10. (H) Characteristic ductogram (long arrow)
and thin strip appearance that spread along glandular tissue was demonstrated in Case 11. Nonmass
and mass. (I) In Case 8, the MPR for ductal orientation revealed both nonmass and mass with ductogram
(long arrow), thick striped appearance, and lesion crossover glandular tissue. (J) In Case 12, the MPR for ductal orientation manifested
as nonmass and mass with partial ductogram (long arrow), thin striped appearance, and lesion crossover glandular tissue. (K) In Case
13, the MPR for ductal orientation appeared as nonmass and mass with partial ductogram (long arrow), thick striped appearance,
and lesion crossover glandular tissue. (L) Case 6 of pure-type DCIS appeared as nonmass intensity (arrow indicates true DICIS area)
and lesion crossover glandular tissue. Magnetic resonance imaging overestimated tumour size by > 200%, compared to the size
revealed by pathological study (curved arrow shows the false area). Mass. (M) Characteristic partial ductogram appearance (long
arrow) and crossing-over glandular tissue appeared in Case 9. DCIS = ductal carcinoma in situ; MPR = multiplanar reformation.
were combined to compose a more convenient platform
to help radiologists diagnose based on images. This works
by actually viewing a specimen of a breast lesion, by 
precisely localising its relationship with the mammary
duct and indirectly detecting its cellular characteristics.
From this retrospective study, malignant breast lesions
are likely to be diagnosed with DBMRI by combining 
MPR with ductal orientation, ESP and the postcontrast
kinetic curve, which act as independent analytical
issues.5,6 Based on our experience, ESP and kinetic curve
are the two parameters that acted as an initial threshold
for predicting malignancy or nonmalignancy. We suggest
using MPR to determine the extent and relationship
between tumour location and the mammary ducts, to 
distinguish DCIS from invasive tumour. They can help
radiologists make a more comprehensive final imaging
diagnosis.5,6
DCIS in the early stage should show a spread-out dis-
tribution that extends toward the nipple, and occasion-
ally is seen in the breast tissue that is peripheral to the
infiltrating carcinoma. Under microscopy, multiple ducts
with DCIS are seen to be connected with each other in
serial sections. Therefore, only 3D demonstrations of
images and pathological samples can be correlated with
each other. It is necessary to consider the breast anatomy
and its relationship with breast cancer pathogenesis.7–9
IDC is the most common form of invasive breast can-
cer, and accounts for more than 80% of all types of breast
cancer. Cancer cells form in the lining of the mammary
duct, and then break through the ductal wall and invade
nearby breast parenchymal tissue. The initial steps in duc-
tal breast cancer invasion occur in a noninvasive DCIS
lesion. By using MRI with MPR for ductal orientation
demonstration, low-grade and typical DCIS can be visu-
alised with a nonmass, strip appearance, spread along the
duct, the glandular tissue and ductogram appearance.
The cross-over part with intensity along the glandular tis-
sue can be identified as a form of DCIS lesion with micro-
invasive foci of transition. On microscopic examination,
the cancerous cells invade and replace the surrounding
normal tissues, and spread beyond the mammary duct.
The early stage of IDC is the most difficult diagnostic
stage, when the cancer cells remain localised and remain
near the site of origin. Using MRI with MPR for ductal
orientation demonstration, the lesion can be visualised
with a focal mass, nonstrip appearance, cross-over glan-
dular tissue and without ductogram appearance. In addi-
tion, more intense enhancement with a larger proportion
of washout pattern in the kinetic curve survey has con-
firmed the diagnosis of high-grade malignancy.10–14
Breast MRI is undoubtedly a useful tool for staging
invasive cancers like IDC.2 However, previous studies on
the sensitivity of MRI for identification of DCIS have
shown large variation. Kuhl et al4,10 have compared mam-
mography and MRI, and have concluded that the latter
was > 2 times more sensitive in detecting DCIS. They have
claimed that MRI found about 92% of DCIS cases, compared
with about 56% for mammography.11 However, there are
limitations to traditional breast MRI systems for analysis of
early DCIS by the sagittal and coronal planes. Although
MRI provides a 3D representation of the enhanced tis-
sues, the borders between DCIS and its surrounding
benign processes are often indistinguishable, especially
when DCIS is scattered sparsely. The actual size based on
pathological examination is also difficult to measure
accurately; this is because of the anatomy of the breast
ducts, which are distributed in three dimensions, whereas
histological sections are in only two. It is difficult to
measure scattered and widely distributed DCIS, which is
one possible explanation for the frequent mismatch
between MRI and pathological findings. In addition, het-
erogeneous DCIS lesions more often exist alongside benign
active tissues or lesions, such as adenosis, sclerosing
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Figure 4. Three kinds of non-DCIS lesions, both benign and
malignant, under MPR with ductal orientation. (A) MPR showed
enhanced thick strip-like intensity with an irregular contour,
which spread along the intraductal structure (arrow) and within
the network (intraductal papilloma). (B) MPR showed an
enhanced and well-defined smooth nodular lesion, which occu-
pied the intraductal area of the non-dilated side with a tadpole
morphology (ductal hyperplasia; arrow). (C) MPR showed a focal
lesion with enhancement (arrow), which crossed over the ducts of
the surrounding glandular structures, and was not continuous
with the ductal structures (early focal intraductal carcinoma).
DCIS = ductal carcinoma in situ; MPR = multiplanar reformation.
adenosis, inflammation and proliferative fibrocystic
changes. According to our observations, MPR with ductal
orientation for anatomical localisation seems to be a useful
technique for early diagnosis of DCIS, especially the ER-
positive form. Characteristic findings include strip mor-
phology, spreading along glandular tissue, and ductogram
appearance. Moreover, MPR is excellent for demonstration
of the anatomical spreading pattern of early intraductal
carcinoma in situ that extends toward the nipple, and its
spatial relationship with the surrounding breast tissue.
These findings should be considered in the surgical strategy
for segmental resection or partial mastectomy.
Breast MRI with MPR for ductal orientation improves
the early detection rate and exhibits higher specificity based
on improved anatomical interpretation of mammary ducts.
However, the existence of adenosis, fibroadenomas and
some specific benign proliferative processes can still inter-
fere with identifying characteristic patterns of MRI findings,
which leads to overestimation of the true size and scope
of the distribution.12
For cases of IDC with a DCIS component, it is difficult
to demonstrate accurately the DCIS part distinguished
from IDC. Some pitfalls exist when matching the 3D DCIS
distribution and the routine 2D histological sectioning.
Using a DBMRI system with Spiral RODEO pulse
sequence, those lesions that could be subtracted in the ESP
were almost completely excluded from the possibility of
being malignant.
According to our previous study that focused on women
with dense and nondense breast tissue,15 which compared
by image interpretations of mammography and breast MRI,
we have found a significantly higher proportion of women
with dense breasts in Taiwan than among Western European
women. From our database that compared the results of the
studies reviewed, we think that it is more difficult to detect
early tumours in Asian women using only mammography.
Thus, using MRI with MPR to detect early cancer like DCIS
is important for Asian women, especially those with dense
breasts.15,16 Furthermore, pathologists should be notified
early of the MRI findings and the lesion size before planning
to resect a specimen that is scheduled for microscopic study.
In the future, we expect better integration of radiologists,
surgeons and pathologists to propose working guidelines,
to create an environment that promotes better correlation
between imaging and pathology. Cumulative experience
will provide more accurate estimation of DCIS volume,
which will improve preoperative image assessment.13,14
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